Matches in Wikidata for { <http://www.wikidata.org/entity/Q37310298> ?p ?o ?g. }
- Q37310298 description "article científic" @default.
- Q37310298 description "article scientifique" @default.
- Q37310298 description "articolo scientifico" @default.
- Q37310298 description "artigo científico" @default.
- Q37310298 description "artículu científicu espublizáu en 2010" @default.
- Q37310298 description "bilimsel makale" @default.
- Q37310298 description "scientific article published on 19 May 2010" @default.
- Q37310298 description "vedecký článok" @default.
- Q37310298 description "vetenskaplig artikel" @default.
- Q37310298 description "videnskabelig artikel" @default.
- Q37310298 description "vědecký článek" @default.
- Q37310298 description "wetenschappelijk artikel" @default.
- Q37310298 description "wissenschaftlicher Artikel" @default.
- Q37310298 description "наукова стаття, опублікована в травні 2010" @default.
- Q37310298 description "научни чланак" @default.
- Q37310298 description "مقالة علمية نشرت في 19 مايو 2010" @default.
- Q37310298 name "Phase I and pharmacokinetic study of erlotinib (OSI-774) in combination with docetaxel in squamous cell carcinoma of the head and neck (SSCHN)." @default.
- Q37310298 name "Phase I and pharmacokinetic study of erlotinib (OSI-774) in combination with docetaxel in squamous cell carcinoma of the head and neck (SSCHN)." @default.
- Q37310298 name "Phase I and pharmacokinetic study of erlotinib" @default.
- Q37310298 type Item @default.
- Q37310298 label "Phase I and pharmacokinetic study of erlotinib (OSI-774) in combination with docetaxel in squamous cell carcinoma of the head and neck (SSCHN)." @default.
- Q37310298 label "Phase I and pharmacokinetic study of erlotinib (OSI-774) in combination with docetaxel in squamous cell carcinoma of the head and neck (SSCHN)." @default.
- Q37310298 label "Phase I and pharmacokinetic study of erlotinib" @default.
- Q37310298 prefLabel "Phase I and pharmacokinetic study of erlotinib (OSI-774) in combination with docetaxel in squamous cell carcinoma of the head and neck (SSCHN)." @default.
- Q37310298 prefLabel "Phase I and pharmacokinetic study of erlotinib (OSI-774) in combination with docetaxel in squamous cell carcinoma of the head and neck (SSCHN)." @default.
- Q37310298 prefLabel "Phase I and pharmacokinetic study of erlotinib" @default.
- Q37310298 P1433 Q37310298-3CA79AA6-1500-47EB-9596-AE05BAFC819B @default.
- Q37310298 P1476 Q37310298-87A038E4-429A-45EE-8ABA-E28478DBA01D @default.
- Q37310298 P2093 Q37310298-2A6F8E7F-628F-47A7-A011-83D55F729AB5 @default.
- Q37310298 P2093 Q37310298-2D06E655-8308-4482-982A-DF386ABC1992 @default.
- Q37310298 P2093 Q37310298-4BA1B3B5-D0F4-4A5E-B41F-FF0E7FF24CBC @default.
- Q37310298 P2093 Q37310298-589B9636-28C5-44AB-A247-B6DF81206B73 @default.
- Q37310298 P2093 Q37310298-61179702-7DC3-4FDB-B43E-0826332818F3 @default.
- Q37310298 P2093 Q37310298-68BDF506-962B-472E-98FC-7F633AB3F50E @default.
- Q37310298 P2093 Q37310298-891CA8BF-5EA1-4905-AF95-3552A56A0490 @default.
- Q37310298 P2093 Q37310298-9288D28B-7FF2-4354-B18B-52D154ABA2EA @default.
- Q37310298 P2093 Q37310298-AFD6EAB0-D952-4FA8-999A-6C955E6F5DCE @default.
- Q37310298 P2093 Q37310298-DE2338E4-FC1B-4623-AE41-921C5371233C @default.
- Q37310298 P2093 Q37310298-E3338DEE-4619-4C5B-824F-5F0B8503BE19 @default.
- Q37310298 P2093 Q37310298-F5735037-F66E-4A7E-B55D-E402DC1E80F1 @default.
- Q37310298 P2860 Q37310298-08D822D6-0E28-48C6-9666-6B1EDA63DCA8 @default.
- Q37310298 P2860 Q37310298-11927981-56B5-4808-8968-20DCBF3D1E3C @default.
- Q37310298 P2860 Q37310298-214BA64B-79B3-4969-8E03-7696042650F6 @default.
- Q37310298 P2860 Q37310298-24193130-88DD-4DCC-8A56-CA1C53331305 @default.
- Q37310298 P2860 Q37310298-2802B32E-0F08-4F50-9F34-39C5620E31AA @default.
- Q37310298 P2860 Q37310298-39028BC5-6530-49A7-8A52-07813C565544 @default.
- Q37310298 P2860 Q37310298-39B41919-E28C-4960-8F2E-AF7D7AF3BB31 @default.
- Q37310298 P2860 Q37310298-49CEF1EA-8B15-484A-B08D-EF9BC474A70B @default.
- Q37310298 P2860 Q37310298-50D9E1FE-6189-4749-B666-F73B76CC5216 @default.
- Q37310298 P2860 Q37310298-6C9A2991-55E5-4DFB-918A-36E0044081A2 @default.
- Q37310298 P2860 Q37310298-75AAE063-6E64-448B-978B-2D2C50EE4EBD @default.
- Q37310298 P2860 Q37310298-891A4067-DD11-4D4F-AC3F-55A08E9B4CA9 @default.
- Q37310298 P2860 Q37310298-966DD3AF-D035-4A11-BE16-13819E3516AA @default.
- Q37310298 P2860 Q37310298-A885FB5B-5532-4155-937E-C3071A22FF1A @default.
- Q37310298 P2860 Q37310298-C96BDC88-DA1A-4D88-9833-CC53D23C7264 @default.
- Q37310298 P2860 Q37310298-C9CE48B7-26D1-441D-B959-C9CE86072267 @default.
- Q37310298 P2860 Q37310298-CEFC1F6A-E722-4BE0-813F-F33FF18C0415 @default.
- Q37310298 P2860 Q37310298-CFBC11CF-810E-4B0D-BEF3-7CE68939126A @default.
- Q37310298 P2860 Q37310298-CFD32A5E-98BF-4B1E-BCA1-B2E1AB3DB121 @default.
- Q37310298 P2860 Q37310298-E32195DF-84BA-4F47-B86C-0ABFDA572764 @default.
- Q37310298 P2860 Q37310298-EE62BBBA-C34E-4959-B3A7-830488CC08C4 @default.
- Q37310298 P2860 Q37310298-EF5BD4FF-2F35-4C81-99BF-6FAE25FF60DA @default.
- Q37310298 P2888 Q37310298-69E24903-A191-4855-AB30-B41D7998B0A1 @default.
- Q37310298 P304 Q37310298-47B7AE18-675C-464D-B34C-CA272B0725C5 @default.
- Q37310298 P31 Q37310298-3B93763E-6177-4403-AB96-03ACB3D49A9A @default.
- Q37310298 P356 Q37310298-2CFCBB18-DCE2-4A58-91A7-8D113F8A15A4 @default.
- Q37310298 P433 Q37310298-361B34CA-5997-44CF-95B5-0AA9E4CA5B5A @default.
- Q37310298 P478 Q37310298-5B6CC772-3D3E-4805-A3C8-1E33BB7BB385 @default.
- Q37310298 P577 Q37310298-B1B21727-BBA9-4BC0-9FB1-38231B9DEB9E @default.
- Q37310298 P698 Q37310298-C556A325-371C-4B78-A2B7-0209E58057E3 @default.
- Q37310298 P921 Q37310298-819F5101-A984-4CA7-AB43-DEEDECE1F899 @default.
- Q37310298 P921 Q37310298-96E1F38D-4557-43CE-97A4-77914FFD8A96 @default.
- Q37310298 P921 Q37310298-9B3AD421-429A-4065-95BC-B744D8A75747 @default.
- Q37310298 P932 Q37310298-B7E8627C-47DC-45AF-9430-55C82A5B0910 @default.
- Q37310298 P356 S00280-010-1332-Y @default.
- Q37310298 P698 20490801 @default.
- Q37310298 P1433 Q326137 @default.
- Q37310298 P1476 "Phase I and pharmacokinetic study of erlotinib (OSI-774) in combination with docetaxel in squamous cell carcinoma of the head and neck (SSCHN)." @default.
- Q37310298 P2093 "Amit Agrawal" @default.
- Q37310298 P2093 "Christopher Rhoades" @default.
- Q37310298 P2093 "Donn C Young" @default.
- Q37310298 P2093 "Eric H Kraut" @default.
- Q37310298 P2093 "Hao Cheng" @default.
- Q37310298 P2093 "James Lang" @default.
- Q37310298 P2093 "Janet Dancey" @default.
- Q37310298 P2093 "Josephine Aimiumu" @default.
- Q37310298 P2093 "Kenneth K Chan" @default.
- Q37310298 P2093 "Michael R Grever" @default.
- Q37310298 P2093 "Ping Chen" @default.
- Q37310298 P2093 "Yilong Zhang" @default.
- Q37310298 P2860 Q27851502 @default.
- Q37310298 P2860 Q27860904 @default.
- Q37310298 P2860 Q28293442 @default.
- Q37310298 P2860 Q33178143 @default.
- Q37310298 P2860 Q33716113 @default.
- Q37310298 P2860 Q33716127 @default.
- Q37310298 P2860 Q33744498 @default.
- Q37310298 P2860 Q34287207 @default.
- Q37310298 P2860 Q34398347 @default.
- Q37310298 P2860 Q34471062 @default.